{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:19:09Z","timestamp":1792448349285,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"DOI":"10.1186\/s12868-025-00966-4","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T19:42:09Z","timestamp":1754077329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of subanesthetic dose of ketamine on motor and cognitive outcomes of harmaline-induced essential tremor model: a focus on Lingo-1 and inflammatory pathways"],"prefix":"10.1186","volume":"26","author":[{"given":"Mehran","family":"Ilaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynab","family":"Pirmoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Esmaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Hosseinalipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Rouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Soltanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Nakhaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiana","family":"Sharififar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2007-3584","authenticated-orcid":false,"given":"Moazamehosadat","family":"Razavinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-5849","authenticated-orcid":false,"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"966_CR1","doi-asserted-by":"crossref","unstructured":"Louis ED, McCreary M. How common is essential tremor? Update on the worldwide prevalence of essential tremor. Tremor Other Hyperkinetic Movements 2021, 11.","DOI":"10.5334\/tohm.632"},{"key":"966_CR2","doi-asserted-by":"crossref","unstructured":"Faust PL. Is essential tremor a degenerative disorder or an electric disorder? Degenerative disorder. Int Rev Neurobiol. Volume 163. edn.: Elsevier; 2022. pp. 65\u2013101.","DOI":"10.1016\/bs.irn.2022.02.003"},{"issue":"3","key":"966_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/ene.15650","volume":"30","author":"L Angelini","year":"2023","unstructured":"Angelini L, Paparella G, De Biase A, Maraone A, Panfili M, Berardelli I, Cannavacciuolo A, Di Vita A, Margiotta R, Fabbrini G. Longitudinal study of clinical and neurophysiological features in essential tremor. Eur J Neurol. 2023;30(3):631\u201340.","journal-title":"Eur J Neurol"},{"key":"966_CR4","doi-asserted-by":"crossref","unstructured":"Okelberry T, Lyons KE, Pahwa R. Updates in essential tremor. Parkinsonism Relat Disord. 2024:106086.","DOI":"10.1016\/j.parkreldis.2024.106086"},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"120198","DOI":"10.1016\/j.jns.2022.120198","volume":"435","author":"M-K Pan","year":"2022","unstructured":"Pan M-K, Kuo S-H. Essential tremor: clinical perspectives and pathophysiology. J Neurol Sci. 2022;435:120198.","journal-title":"J Neurol Sci"},{"key":"966_CR6","doi-asserted-by":"crossref","unstructured":"van den Berg KR, Helmich RC. The role of the cerebellum in tremor\u2013evidence from neuroimaging. Tremor Other Hyperkinetic Movements. 2021, 11.","DOI":"10.5334\/tohm.660"},{"issue":"5","key":"966_CR7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1212\/CON.0000000000001181","volume":"28","author":"AW Shukla","year":"2022","unstructured":"Shukla AW. Diagnosis and treatment of essential tremor. CONTINUUM: Lifelong Learn Neurol. 2022;28(5):1333\u201349.","journal-title":"CONTINUUM: Lifelong Learn Neurol"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1017\/erm.2019.7","volume":"21","author":"H Deng","year":"2019","unstructured":"Deng H, Wu S, Jankovic J. Essential tremor: genetic update. Expert Rev Mol Med. 2019;21:e8.","journal-title":"Expert Rev Mol Med"},{"key":"966_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00401-013-1108-7","volume":"125","author":"S-H Kuo","year":"2013","unstructured":"Kuo S-H, Tang G, Louis ED, Ma K, Babji R, Balatbat M, Cortes E, Vonsattel J-PG, Yamamoto A, Sulzer D. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol. 2013;125:879\u201389.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"966_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13287-021-02452-0","volume":"12","author":"C-G Zhao","year":"2021","unstructured":"Zhao C-G, Qin J, Li J, Jiang S, Ju F, Sun W, Ren Z, Ji Y-Q, Wang R, Sun X-L. LINGO-1 regulates Wnt5a signaling during neural stem and progenitor cell differentiation by modulating miR-15b-3p levels. Stem Cell Res Ther. 2021;12(1):372.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"966_CR11","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.3390\/cimb44050149","volume":"44","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Zou S. A glance at the molecules that regulate oligodendrocyte myelination. Curr Issues Mol Biol. 2022;44(5):2194\u2013216.","journal-title":"Curr Issues Mol Biol"},{"key":"966_CR12","doi-asserted-by":"crossref","unstructured":"Lan L, Zhao X, Jian S, Li C, Wang M, Zhou Q, Huang S, Zhu S, Kang H, Kirsch HE. Investigation of the risk of valproic acid\u2013induced tremor: clinical, neuroimaging, and genetic factors. Psychopharmacology. 2022:1\u201312.","DOI":"10.1007\/s00213-021-06004-5"},{"issue":"13","key":"966_CR13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/mds.25819","volume":"29","author":"C Delay","year":"2014","unstructured":"Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, Rajput A, Calon F. Increased LINGO1 in the cerebellum of essential tremor patients. Mov Disord. 2014;29(13):1637\u201347.","journal-title":"Mov Disord"},{"issue":"11","key":"966_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/00207454.2020.1865952","volume":"132","author":"ZM Muruzheva","year":"2022","unstructured":"Muruzheva ZM, Ivleva IS, Traktirov DS, Zubov AS, Karpenko MN. The relationship between serum interleukin-1\u03b2, interleukin-6, interleukin-8, interleukin-10, tumor necrosis factor-\u03b1 levels and clinical features in essential tremor. Int J Neurosci. 2022;132(11):1143\u20139.","journal-title":"Int J Neurosci"},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"107472","DOI":"10.1016\/j.clineuro.2022.107472","volume":"222","author":"ZM Muruzheva","year":"2022","unstructured":"Muruzheva ZM, Traktirov DS, Tumashova OS, Karpenko MN. Cluster analysis of clinical, biochemical and electrophysiological features of essential tremor patients. Exploratory study. Clin Neurol Neurosurg. 2022;222:107472.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"966_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/acn3.758","volume":"6","author":"YL Ong","year":"2019","unstructured":"Ong YL, Deng X, Tan EK. Etiologic links between environmental and lifestyle factors and essential tremor. Ann Clin Transl Neurol. 2019;6(5):979\u201389.","journal-title":"Ann Clin Transl Neurol"},{"key":"966_CR17","doi-asserted-by":"publisher","first-page":"135881","DOI":"10.1016\/j.neulet.2021.135881","volume":"753","author":"\u00d6 Akman","year":"2021","unstructured":"Akman \u00d6, Utkan T, Ar\u0131c\u0131o\u011flu F, G\u00fcll\u00fc K, Ate\u015f N, Karson A. Agmatine has beneficial effect on harmaline-induced essential tremor in rat. Neurosci Lett. 2021;753:135881.","journal-title":"Neurosci Lett"},{"key":"966_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2019.12.045","volume":"429","author":"B Kosmowska","year":"2020","unstructured":"Kosmowska B, Ossowska K, Konieczny J, Lenda T, Berghauzen-Maciejewska K, Wardas J. Inhibition of excessive glutamatergic transmission in the ventral thalamic nuclei by a selective adenosine A1 receptor agonist, 5\u2032-chloro-5\u2032-deoxy-(\u00b1)-ENBA underlies its tremorolytic effect in the harmaline-induced model of essential tremor. Neuroscience. 2020;429:106\u201318.","journal-title":"Neuroscience"},{"key":"966_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuro.2023.10.005","volume":"99","author":"X Zhan","year":"2023","unstructured":"Zhan X, Do LV, Zou L, Zhan RS, Jones M, Nawaz S, Manaye K. Harmaline toxicity on dorsal striatal neurons and its role in tremor. Neurotoxicology. 2023;99:152\u201361.","journal-title":"Neurotoxicology"},{"key":"966_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ibneur.2024.08.005","volume":"17","author":"H Abbassian","year":"2024","unstructured":"Abbassian H, Ilaghi M, Amleshi RS, Whalley BJ, Shabani M. Modulation of CB1 cannabinoid receptor alters the electrophysiological properties of cerebellar purkinje cells in harmaline-induced essential tremor. IBRO Neurosci Rep. 2024;17:196\u2013206.","journal-title":"IBRO Neurosci Rep"},{"key":"966_CR21","first-page":"5798285","volume":"20201","author":"A Pribish","year":"2020","unstructured":"Pribish A, Wood N, Kalava A. A review of nonanesthetic uses of ketamine. Anesthesiol Res Pract. 2020;20201:5798285.","journal-title":"Anesthesiol Res Pract"},{"issue":"10","key":"966_CR22","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.2174\/0929867325666181112094330","volume":"27","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2020","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JA. An update on the neurochemistry of essential tremor. Curr Med Chem. 2020;27(10):1690\u2013710.","journal-title":"Curr Med Chem"},{"issue":"6","key":"966_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/1570159X18666200124145743","volume":"18","author":"H Alonso-Navarro","year":"2020","unstructured":"Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JA, Jim\u00e9nez-Jim\u00e9nez FJ. Current and future neuropharmacological options for the treatment of essential tremor. Curr Neuropharmacol. 2020;18(6):518\u201337.","journal-title":"Curr Neuropharmacol"},{"issue":"1\u20133","key":"966_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2012.08.014","volume":"695","author":"FR Shourmasti","year":"2012","unstructured":"Shourmasti FR, Goudarzi I, Lashkarbolouki T, Abrari K, Salmani ME, Goudarzi A. Effects of riluzole on harmaline induced tremor and ataxia in rats: biochemical, histological and behavioral studies. Eur J Pharmacol. 2012;695(1\u20133):40\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"966_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuropharm.2011.05.015","volume":"61","author":"PK Iseri","year":"2011","unstructured":"Iseri PK, Karson A, Gullu KM, Akman O, Kokturk S, Yard\u00fdmoglu M, Erturk S, Ates N. The effect of memantine in harmaline-induced tremor and neurodegeneration. Neuropharmacology. 2011;61(4):715\u201323.","journal-title":"Neuropharmacology"},{"key":"966_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2015.01.078","volume":"590","author":"Z Vaziri","year":"2015","unstructured":"Vaziri Z, Abbassian H, Sheibani V, Haghani M, Nazeri M, Aghaei I, Shabani M. The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor. Neurosci Lett. 2015;590:84\u201390.","journal-title":"Neurosci Lett"},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"109383","DOI":"10.1016\/j.neuropharm.2022.109383","volume":"225","author":"X-H Tang","year":"2023","unstructured":"Tang X-H, Diao Y-G, Ren Z-Y, Zang Y-Y, Zhang G-F, Wang X-M, Duan G-F, Shen J-C, Hashimoto K, Zhou Z-Q. A role of GABAA receptor \u03b11 subunit in the hippocampus for rapid-acting antidepressant-like effects of ketamine. Neuropharmacology. 2023;225:109383.","journal-title":"Neuropharmacology"},{"key":"966_CR28","doi-asserted-by":"publisher","first-page":"104669","DOI":"10.1016\/j.nbd.2019.104669","volume":"134","author":"S Ghosal","year":"2020","unstructured":"Ghosal S, Duman CH, Liu R-J, Wu M, Terwilliger R, Girgenti MJ, Wohleb E, Fogaca MV, Teichman EM, Hare B. Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents. Neurobiol Dis. 2020;134:104669.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"966_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cns.12104","volume":"19","author":"M De Kock","year":"2013","unstructured":"De Kock M, Loix S, Lavand\u2019homme P. Ketamine and peripheral inflammation. CNS Neurosci Ther. 2013;19(6):403\u201310.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"966_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41398-020-00933-z","volume":"10","author":"Y Zhan","year":"2020","unstructured":"Zhan Y, Zhou Y, Zheng W, Liu W, Wang C, Lan X, Deng X, Xu Y, Zhang B, Ning Y. Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder. Trans Psychiatry. 2020;10(1):246.","journal-title":"Translational Psychiatry"},{"key":"966_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ebiom.2019.10.063","volume":"50","author":"W Nowak","year":"2019","unstructured":"Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena \u00c1R, Eberhardt N, Rodante DE, Aoki MP, Daray FM, Silva EAC. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019;50:290\u2013305.","journal-title":"EBioMedicine"},{"issue":"04","key":"966_CR32","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.4103\/ajns.AJNS_47_18","volume":"14","author":"S Sokhal","year":"2019","unstructured":"Sokhal S, Goyal K, Sokhal N, Kumar N, Kedia S. Intraoperative management of a patient for deep brain stimulation with severe dyskinesia and tremors: ketamine to the rescue! Asian J Neurosurg. 2019;14(04):1275\u20136.","journal-title":"Asian J Neurosurg"},{"issue":"3","key":"966_CR33","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1213\/ane.0b013e3181924025","volume":"108","author":"JJ Wright","year":"2009","unstructured":"Wright JJ, Goodnight PD, McEvoy MD. The utility of ketamine for the preoperative management of a patient with parkinson\u2019s disease. Anesth Analgesia. 2009;108(3):980\u20132.","journal-title":"Anesth Analgesia"},{"issue":"2","key":"966_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00415-020-10326-3","volume":"268","author":"C Nencini","year":"2021","unstructured":"Nencini C, De Santis V, Fusari M. Unexpected ketamine effect in a patient with cervical dystonia. J Neurol. 2021;268(2):712\u20133.","journal-title":"J Neurol"},{"issue":"10","key":"966_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.apjtm.2017.09.014","volume":"10","author":"J-C Fan","year":"2017","unstructured":"Fan J-C, Song J-J, Wang Y, Chen Y, Hong D-X. Neuron-protective effect of subanesthestic-dosage ketamine on mice of parkinson\u2019s disease. Asian Pac J Trop Med. 2017;10(10):1007\u201310.","journal-title":"Asian Pac J Trop Med"},{"key":"966_CR36","doi-asserted-by":"publisher","first-page":"110047","DOI":"10.1016\/j.neuropharm.2024.110047","volume":"257","author":"CJ Stopera","year":"2024","unstructured":"Stopera CJ, Bartlett MJ, Liu C, Esqueda A, Parmar R, Heien ML, Sherman SJ, Falk T. Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model. Neuropharmacology. 2024;257:110047.","journal-title":"Neuropharmacology"},{"issue":"1","key":"966_CR37","doi-asserted-by":"publisher","first-page":"9864","DOI":"10.1038\/s41598-024-60518-4","volume":"14","author":"Z Pirmoradi","year":"2024","unstructured":"Pirmoradi Z, Nakhaie M, Ranjbar H, Kalantar-Neyestanaki D, Kohlmeier KA, Asadi-Shekaari M, Hassanshahi A, Shabani M. Resveratrol and 1, 25-dihydroxyvitamin D decrease Lingo-1 levels, and improve behavior in harmaline-induced essential tremor, suggesting potential therapeutic benefits. Sci Rep. 2024;14(1):9864.","journal-title":"Sci Rep"},{"key":"966_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neulet.2019.04.017","volume":"704","author":"F Mohammadi","year":"2019","unstructured":"Mohammadi F, Esfahlani MA, Shabani M. Erythropoietin ameliorates harmaline-induced essential tremor and cognition disturbances. Neurosci Lett. 2019;704:153\u20138.","journal-title":"Neurosci Lett"},{"issue":"1","key":"966_CR39","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1038\/s41598-023-33016-2","volume":"13","author":"M Shabani","year":"2023","unstructured":"Shabani M, Ilaghi M, Naderi R, Razavinasab M. The hyperexcitability of laterodorsal tegmentum cholinergic neurons accompanies adverse behavioral and cognitive outcomes of prenatal stress. Sci Rep. 2023;13(1):6011.","journal-title":"Sci Rep"},{"key":"966_CR40","doi-asserted-by":"crossref","unstructured":"Schmittgen TD. Real-time quantitative PCR. 2001.","DOI":"10.1006\/meth.2001.1260"},{"key":"966_CR41","doi-asserted-by":"crossref","unstructured":"Gironell A. The GABA hypothesis in essential tremor: lights and shadows. Tremor Other Hyperkinetic Movements. 2014, 4.","DOI":"10.5334\/tohm.229"},{"key":"966_CR42","doi-asserted-by":"crossref","unstructured":"Zhang X, Santaniello S. Role of cerebellar GABAergic dysfunctions in the origins of essential tremor. Proc Natil Acad Sci. 2019; 116(27):13592\u201313601.","DOI":"10.1073\/pnas.1817689116"},{"key":"966_CR43","doi-asserted-by":"crossref","unstructured":"Handforth A, Singh RP, Treven M, Ernst M. Search for novel therapies for essential tremor based on positive modulation of \u03b16-containing GABAA receptors. Tremor Other Hyperkinetic Movements. 2023, 13.","DOI":"10.5334\/tohm.796"},{"key":"966_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00234-016-1771-1","volume":"59","author":"A Lenka","year":"2017","unstructured":"Lenka A, Bhalsing KS, Panda R, Jhunjhunwala K, Naduthota RM, Saini J, Bharath RD, Yadav R, Pal PK. Role of altered cerebello-thalamo-cortical network in the neurobiology of essential tremor. Neuroradiology. 2017;59:157\u201368.","journal-title":"Neuroradiology"},{"key":"966_CR45","doi-asserted-by":"crossref","unstructured":"Handforth A. Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor. Tremor Other Hyperkinetic Movements. 2012, 2.","DOI":"10.5334\/tohm.108"},{"issue":"2","key":"966_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0091-3057(91)90571-I","volume":"40","author":"M Irifune","year":"1991","unstructured":"Irifune M, Shimizu T, Nomoto M. Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav. 1991;40(2):399\u2013407.","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"966_CR47","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","volume":"27","author":"A Becker","year":"2003","unstructured":"Becker A, Peters B, Schroeder H, Mann T, Huether G, Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(4):687\u2013700.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"966_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jocn.2018.11.004","volume":"59","author":"I Aghaei","year":"2019","unstructured":"Aghaei I, Hajali V, Haghani M, Vaziri Z, Moosazadeh M, Shabani M. Peroxisome proliferator-activated receptor-\u03b3 activation attenuates harmaline-induced cognitive impairments in rats. J Clin Neurosci. 2019;59:276\u201383.","journal-title":"J Clin Neurosci"},{"key":"966_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2015.11.047","volume":"612","author":"MJ Bartlett","year":"2016","unstructured":"Bartlett MJ, Joseph RM, LePoidevin LM, Parent KL, Laude ND, Lazarus LB, Heien ML, Estevez M, Sherman SJ, Falk T. Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model. Neurosci Lett. 2016;612:121\u20135.","journal-title":"Neurosci Lett"},{"key":"966_CR50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00213-014-3697-9","volume":"232","author":"L-M Zhang","year":"2015","unstructured":"Zhang L-M, Zhou W-W, Ji Y-J, Li Y, Zhao N, Chen H-X, Xue R, Mei X-G, Zhang Y-Z, Wang H-L. Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder. Psychopharmacology. 2015;232:663\u201372.","journal-title":"Psychopharmacology"},{"issue":"2","key":"966_CR51","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.neuroscience.2009.03.038","volume":"161","author":"E Engin","year":"2009","unstructured":"Engin E, Treit D, Dickson C. Anxiolytic-and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience. 2009;161(2):359\u201369.","journal-title":"Neuroscience"},{"issue":"3","key":"966_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.brainresbull.2006.01.010","volume":"69","author":"G Imre","year":"2006","unstructured":"Imre G, Fokkema DS, Den Boer JA, Ter Horst GJ. Dose\u2013response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res Bull. 2006;69(3):338\u201345.","journal-title":"Brain Res Bull"},{"issue":"1","key":"966_CR53","first-page":"55","volume":"57","author":"M Mandryk","year":"2005","unstructured":"Mandryk M, Fidecka S, Poleszak E, Malec D. Participation of adenosine system in the ketamine-induced motor activity in mice. Pharmacol Rep. 2005;57(1):55\u201360.","journal-title":"Pharmacol Rep"},{"issue":"11","key":"966_CR54","doi-asserted-by":"publisher","first-page":"e23468","DOI":"10.1002\/jbt.23468","volume":"37","author":"MM Ommati","year":"2023","unstructured":"Ommati MM, Mobasheri A, Niknahad H, Rezaei M, Alidaee S, Arjmand A, Mazloomi S, Abdoli N, Sadeghian I, Sabouri S. Low-dose ketamine improves animals\u2019 locomotor activity and decreases brain oxidative stress and inflammation in ammonia\u2010induced neurotoxicity. J Biochem Mol Toxicol. 2023;37(11):e23468.","journal-title":"J Biochem Mol Toxicol"},{"issue":"3","key":"966_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.pbb.2011.10.014","volume":"100","author":"K Akillioglu","year":"2012","unstructured":"Akillioglu K, Melik EB, Melik E, Boga A. Effect of ketamine on exploratory behaviour in BALB\/C and C57BL\/6 mice. Pharmacol Biochem Behav. 2012;100(3):513\u20137.","journal-title":"Pharmacol Biochem Behav"},{"key":"966_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbr.2013.08.017","volume":"256","author":"Y Usun","year":"2013","unstructured":"Usun Y, Eybrard S, Meyer F, Louilot A. Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional Blockade of the prefrontal cortex. Behav Brain Res. 2013;256:229\u201337.","journal-title":"Behav Brain Res"},{"issue":"22","key":"966_CR57","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.lfs.2006.07.004","volume":"79","author":"DJ Moura","year":"2006","unstructured":"Moura DJ, Rorig C, Vieira DL, Henriques JAP, Roesler R, Saffi J, Boeira JM. Effects of \u03b2-carboline alkaloids on the object recognition task in mice. Life Sci. 2006;79(22):2099\u2013104.","journal-title":"Life Sci"},{"key":"966_CR58","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fphar.2018.00346","volume":"9","author":"S-P Li","year":"2018","unstructured":"Li S-P, Wang Y-W, Qi S-L, Zhang Y-P, Deng G, Ding W-Z, Ma C, Lin Q-Y, Guan H-D, Liu W. Analogous \u03b2-carboline alkaloids harmaline and Harmine ameliorate scopolamine-induced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice. Front Pharmacol. 2018;9:346.","journal-title":"Front Pharmacol"},{"issue":"8","key":"966_CR59","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/bioengineering10080941","volume":"10","author":"HF Spencer","year":"2023","unstructured":"Spencer HF, Boese M, Berman RY, Radford KD, Choi KH. Effects of a subanesthetic ketamine infusion on inflammatory and behavioral outcomes after closed head injury in rats. Bioengineering. 2023;10(8):941.","journal-title":"Bioengineering"},{"issue":"1","key":"966_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12974-022-02434-w","volume":"19","author":"HF Spencer","year":"2022","unstructured":"Spencer HF, Berman RY, Boese M, Zhang M, Kim SY, Radford KD, Choi KH. Effects of an intravenous ketamine infusion on inflammatory cytokine levels in male and female Sprague\u2013Dawley rats. J Neuroinflamm. 2022;19(1):75.","journal-title":"J Neuroinflamm"},{"issue":"8","key":"966_CR61","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1517\/14728222.2015.1028360","volume":"19","author":"JA Agundez","year":"2015","unstructured":"Agundez JA, Jim\u00e9nez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E. The potential of LINGO-1 as a therapeutic target for essential tremor. Expert Opin Ther Targets. 2015;19(8):1139\u201348.","journal-title":"Expert Opin Ther Targets"},{"key":"966_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40263-013-0068-8","volume":"27","author":"S Mi","year":"2013","unstructured":"Mi S, Blake Pepinsky R, Cadavid D. Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic. CNS Drugs. 2013;27:493\u2013503.","journal-title":"CNS Drugs"},{"issue":"6","key":"966_CR63","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nn1460","volume":"8","author":"S Mi","year":"2005","unstructured":"Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci. 2005;8(6):745\u201351.","journal-title":"Nat Neurosci"},{"issue":"1","key":"966_CR64","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1523\/JNEUROSCI.4175-06.2007","volume":"27","author":"X Lee","year":"2007","unstructured":"Lee X, Yang Z, Shao Z, Rosenberg SS, Levesque M, Pepinsky RB, Qiu M, Miller RH, Chan JR, Mi S. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci. 2007;27(1):220\u20135.","journal-title":"J Neurosci"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-025-00966-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:49:25Z","timestamp":1757335765000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-025-00966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1186\/s12868-025-00966-4","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were done in accordance with the ARRIVE guidelines and National Institutes of Health Guide for the Care and Use of Laboratory Animals) NIH Publication No. 80\u201323, revised 1996). All experiments were performed in accordance with the protocols approved by Kerman University of Medical Sciences Laboratory Animal Care and was accepted by the Institutional Review Board (IRB) of Kerman University of Medical Sciences (IRB code: IR.KMU.REC.1401.017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that no conflict of interest in present. The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"49"}}